Primary Care Innovation Fund

PRIMARY CARE INNOVATION FUND

Primary Care Innovation Fund

Philadelphia College of Osteopathic Medicine has committed $5 million to a venture capital fund in an effort to stimulate innovation and entrepreneurship in the field of health care, with a specific focus on primary care.

The Primary Care Innovation Fund is the first such endeavor in the history of PCOM. The Fund will review submissions for funding from both within and outside the PCOM community. Our focus is on fully formed companies where a proof of concept has already been established—companies that are beyond the early research stage, with some level of commercial success.

“The osteopathic philosophy focuses on prevention and maintaining wellness, and seeing the patient as a whole person—not just their symptoms. Through the Primary Care Innovation Fund, PCOM can extend that philosophy by investing in innovative opportunities nationally to improve and maintain patients' quality of life.” — Jay S. Feldstein, DO ’81, president and CEO of PCOM

The Primary Care Innovation Fund underscores PCOM's commitment to the advancement of knowledge and intellectual growth, and to the well-being of the wider community through leadership and service.

Dean Miller oversees the fund. He is also president and CEO of PACT (Philadelphia Alliance for Capital & Technologies).

Fund Essentials

The Primary Care Innovation Fund is focused on primary care in a broad perspective. This means companies and technologies that contribute to better patient care outcomes, and advances in fighting chronic diseases such as diabetes, obesity, hypertension, and heart disease. Additional examples include efforts toward better nutrition, services that promote better overall health, and similar endeavors.
The Fund is nationwide in scale, with special attention paid to the healthcare communities in Philadelphia and Atlanta, where PCOM's two campuses are located.
An advisory committee, made up of accomplished physicians and business professionals, assists the Fund in sourcing deals, due diligence, and portfolio management.
For more information, read the Frequently Asked Questions section.